Close Menu

marketing agreement

NEW YORK (GenomeWeb News) – Applied Spectral Imaging and BioDot today announced an agreement to sell and market a genetic analysis solution combining technologies from both firms.

NEW YORK (GenomeWeb News) – Foundation Medicine and Memorial Sloan-Kettering Cancer Center today said they are partnering to co-develop a molecular diagnostic tool to match patients who have hematologic cancers with the most appropriate targeted therapies or clinical trials.

NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

NEW YORK (GenomeWeb News) – Predictive Biosciences will offer its molecular diagnostic bladder cancer tests to Arup Laboratories' national network of clients under a deal announced today.

NEW YORK (GenomeWeb News) – Eastern Biotech and Life Sciences, Dubai and BGI Health have partnered to make available to parts of the Middle East a non-invasive prenatal diagnostic test for detecting trisomy 21.

NEW YORK (GenomeWeb News) – Arup Laboratories has become the latest lab to sign a deal to offer Natera's Panorama non-invasive prenatal screening test.

NEW YORK (GenomeWeb News) – Pathwork Diagnostics today announced a deal to offer its Pathwork Tissue of Origin Test for cancer diagnosis in China.

NEW YORK (GenomeWeb News) – Genetic testing laboratory Pathway Genomics today announced a partnership with Practice Fusion to offer its services to Practice Fusion's network of more than 150,000 medical professionals.

NEW YORK (GenomeWeb News) – NextGxDx will begin offering PreventionGenetics' test catalog through the NextGxDx platform under an agreement announced today.

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has signed an agreement to offer a non-invasive prenatal test developed by Natera.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.